Breakthrough in Lung Cancer: Imfinzi’s FDA Approval for Limited-Stage SCLC Patients
AstraZeneca’s (AZ) Imfinzi (durvalumab) has received approval from the US Food and Drug Administration (FDA) for treating adults…
AstraZeneca’s (AZ) Imfinzi (durvalumab) has received approval from the US Food and Drug Administration (FDA) for treating adults…